Skip to main content
Francesco Barletta on Muck Rack

Francesco Barletta

As seen in: Nature, Wiley Online Library, JAMA Network, European Urology, Canadian Urological Association Journal, EJSO - European Journal of Surgical Oncology, BJU International Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Francesco

Contact Francesco, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Performance of MRI-Based vs Clinical T Staging in Localized Prostate Cancer

|
By Arthur Peyrottes, Michael Baboudjian, Thibaut Long-Depaquit, Morgan Rouprêt, Thierry Roumeguère, Alexandre Peltier, Romain Diamand, Julien Anract, Gregoire Assenmacher, Francesco Barletta, Eric Barret, Edoardo Beatrici, Daniel Benamran, Vincent Benard, Claudio Brancelli, Norbert De Brek, Laurent Brureau, Marie Chicaud, Mathieu Coscarella, Charles Dariane, Igor Duquesne, Mariaconsiglia Ferriero, Gaelle Fiard, Giorgio Gandaglia, Alexander Giesen, Ruben De Groote, Ruth Himmelsbach, Serge Holz, Steven Joniau, Stephan Levy, Thibaut Long Depaquit, Charles Mazeaud, Benoit Mesnard, Stefano Moretto, Yann Neuzillet, Marco Oderda, Jonathan Olivier, Dimitri Paillusson, Frederic Panthier, Maxime Pattou, Andreas Røder, Pietro Scilipoti, August Sigle, Hein Vincent Stroomberg, Fayek Taha, Julien Van Damme, Thibaut Waeckel, Olivier Windisch, iTNM Consortium, Nathan Bergier, Léa Bollen, Marvin Jourdan, Romain Lefranc, Myky Nguyen, Alberto Sasia, Gabrielle Tissot
| JAMA Network Verified
Performance of MRI-Based vs Clinical T Staging in Localized Prostate Cancer Supplement 1. eFigure 1. Proposal of a new T classification system based on multiparametric magnetic resonance imaging by Baboudjian et al., European Urology Oncology, 2023 eFigure 2. Stage migration between clinical (DRE-based) and MRI-based T classification. eFigure 3. Kaplan-Meier curves of A. biochemical recurrence-free survival, and B. distant metastasis-free survival of the whole population.
Open in Who Shared Issue with article?

Re: Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer

|
By Francesco Barletta
| European Urology Verified
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Open in Who Shared View Duplicates (694) Issue with article?

Five‐year outcomes of TOOKAD® (WST‐11) vascular‐targeted photodynamic therapy for low‐risk prostate cancer patients: Insights from a tertiary referral centre

|
By Andrea Cosenza, Francesco Barletta, Leonardo Quarta, Michele Brancaccio
| BJU International Journal Verified
Prostate cancer (PCa) is most commonly diagnosed in its localized stage, with radical treatments such as prostatectomy or radiotherapy offering high rates of cancer control.1 However, these curative options are frequently associated with significant adverse effects, including erectile dysfunction and urinary incontinence, which can negatively impact patients' quality of life.2 In response, interest in organ-sparing approaches has increased, particularly for patients with low-risk disease...
Open in Who Shared Issue with article?
See all 10 articles